The U.S. market for Over-the-Counter (OTC) Pain Medication presents an in-depth analysis of the performance of various analgesics, including non-steroidal anti-inflammatory drugs (NSAID) and topical products in the US market. The analysis captures the performance of the market players, categories and leading brands in terms of revenue growth and volume growth. It also identifies key issues, drivers, challenges, regulations and trends affecting the marketplace.
The report provides a comprehensive analysis of the pain medication products that are currently in the market, as well as those likely to enter the market in future. The study focuses on the market movements and the factors that will fuel sustainable growth. The markets for these products range from the new and emerging, to the comparatively matured. Apart from the broad classification of external and internal analgesics, OTC pain medication products have been categorized into the following five generic groups for the purposes of this study:
- Other NSAIDs (Ibuprofen, Ketoprofen & Naproxen)
- Combination formulations
- Topical analgesics (external analgesics)
Historical data are provided for 2000 through 2004. Compounded annual growth rates (CAGR) are provided for the periods 2000-2004, with forecast data from 2005 to 2009.